ChromoGenics Past Earnings Performance

Past criteria checks 0/6

ChromoGenics has been growing earnings at an average annual rate of 8.7%, while the Building industry saw earnings growing at 17.9% annually. Revenues have been declining at an average rate of 5.7% per year.

Key information

8.7%

Earnings growth rate

84.1%

EPS growth rate

Building Industry Growth18.8%
Revenue growth rate-5.7%
Return on equity-122.8%
Net Margin-334.4%
Next Earnings Update23 May 2024

Recent past performance updates

Recent updates

Does ChromoGenics (STO:CHRO) Have A Healthy Balance Sheet?

Feb 08
Does ChromoGenics (STO:CHRO) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown
Beta

How ChromoGenics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:CHRO Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2316-53530
30 Sep 2319-48520
30 Jun 2323-49560
31 Mar 2322-52570
31 Dec 2224-57590
30 Sep 2233-60610
30 Jun 2236-56570
31 Mar 2235-70720
31 Dec 2129-64660
30 Sep 2120-57590
30 Jun 2115-65590
31 Mar 2116-54450
31 Dec 2020-62520
30 Sep 2024-77620
30 Jun 2034-82680
31 Mar 2042-81690
31 Dec 1946-78660
30 Sep 1944-7878-11
30 Jun 1930-7067-8
31 Mar 1920-6958-3
31 Dec 1811-73540
30 Sep 185-703016
30 Jun 189-713016
31 Mar 188-652715
31 Dec 177-572114
30 Sep 176-491715
30 Jun 174-461417
31 Mar 174-501322
31 Dec 163-491226
30 Sep 163-511131
31 Dec 150-44737
31 Dec 140-32725

Quality Earnings: CHRO is currently unprofitable.

Growing Profit Margin: CHRO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CHRO is unprofitable, but has reduced losses over the past 5 years at a rate of 8.7% per year.

Accelerating Growth: Unable to compare CHRO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CHRO is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (-10.2%).


Return on Equity

High ROE: CHRO has a negative Return on Equity (-122.81%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.